KFDA to tighten post supervision against human placenta preparations.

Published: 2005-12-13 06:58:00

Updated: 2005-12-13 06:58:00

A government control on human placenta preparations in the market seems to be tightened with periodical checking on its quality, pharmaceutical supervision at the production plant and obligation to submit the placenta donor's agreement whenever crude placenta being collected for the use of medici...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK